Complications Developed After Using Byetta. An Arkansas man claims that taking the type 2 diabetes drug Byetta caused him to develop pancreatic cancer. After developing pancreatic cancer and beginning chemotherapy and radiation therapies, the man also developed jaundice. His lawsuit against Amylin Pharmaceuticals Inc. and Eli … [Read more...]
Arkansas Man Claims Byetta Caused Pancreatic Cancer
Byetta, Januvia Cancer Risks Debated
Byetta, Januvia Cancer Risks. The uncertainty surrounding type 2 diabetes drugs like Byetta and Januvia have prompted calls for more studies of glucagon-like peptide 1 (GLP-1) therapies. A recent study has tied Byetta and Januvia to a possible increased risk of pancreatic cancer, but other researchers, along with the drug's … [Read more...]
Byetta, Victoza Raise More Cancer Fears
Byetta Increased The Risk Of Pancreatic Cancer. A new study is adding to concerns that type 2 drugs like Byetta and Victoza could increase the likelihood that a patient will develop pancreatitis and pancreatic cancer. The study found that Byetta increases the risk for pancreatitis - a known risk factor for pancreatic cancer - by … [Read more...]
Byetta Safety Questions
Safety Concerns About Byetta. A new report from the Institute for Safe Medicine Practices (ISMP) may raise safety concerns about a new generation of diabetes drugs, including Byetta. While the group’s new QuarterWatch report discusses another drug called Victoza and pancreatitis, the ISMP raises concerns that similar diabetes … [Read more...]
Byetta Cancer Lawsuit Filed in Florida
A Byetta lawsuit filed in Florida last year claims the Type II Diabetes drug caused pancreatic and liver cancer. The Byetta cancer lawsuit alleges Amylin Pharmaceuticals and Eli Lilly negligently marketed Byetta, and breached warranty by failing to adequately test it or warn consumers of its dangers. Fred J. Salem was prescribed … [Read more...]
Byetta More Safety Studies
Agency wants the studies to asses the drug’s risk of inflammation of the pancreas, acute renal failure and thyroid neoplasms. The Food & Drug Administration (FDA) is requiring Amylin Pharmaceuticals to conduct more safety studies of its type 2 diabetes drug, Byetta. The agency wants the studies to asses the drug's risk of … [Read more...]
Another Byetta Delay
Byetta Probe Extension Sought. Federal regulators are extending a review of the diabetes drug Byetta into next year, Forbes.com is reporting. The Food & Drug Administration (FDA) is considering whether or not to approve Byetta as a stand-alone treatment for diabetes. Right now the drug, jointly marketed by Amylin … [Read more...]
